CVD
COPD and CVD comorbidity
Optimal management of COPD should include identification and management of comorbidities. As COPD has a high rate of comorbidity with cardiovascular disease, patients with COPD may benefit from cardioprotective medications …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …
Targeting secondary cardiovascular events
Low-dose Xarelto has been listed on the PBS in combination with aspirin, for the prevention of major cardiovascular events in high-risk patients While pharmacists have been familiar with Xarelto (rivaroxaban) …
Women overlooked for CVD checks in general practice
With men more likely than women to have their cardiovascular disease risk factors measured by their GP, can pharmacists help bridge the divide? Research from The George Institute for Global …
The week in review
We take a look back at the last week in Australian pharmacy It’s been a tough week for the industry. This week, pharmacy was talking—again—about complementary medicines, following Four Corners‘ …
Profit over patients? Looking deeper into pharmacy CV checks
An article published by a doctor’s publication doesn’t tell the full story, says researcher A recent article in the Australian Doctor website called “Profit over patients? Concerns about pharmacy CV checks” …
New polypill to tackle cardiovascular disease
Two Australian organisations will work together to develop a new four-in-one tablet, designed to reduce the impact of heart disease and stroke Bupa Australia and The George Institute for Global Health have …